Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
12:07
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

WFH 2014 World Congress

 

11-15 May 2014 Melbourne
FAQs
   
Discussion forum - WFH 2014 World Congress
    Topic - Inhibitors, Pathogenesis, Prevention and Treatment

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 63
Visits: 314
Title: A Phase III clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in hemophilia patients with inhibitors: hemostatic efficacy and safety
Authors: YUICHI SHINKODA ,
Centre: Kagoshima City Hospital

You must be registered to reply or comment.

A PHASE III CLINICAL TRIAL OF A MIXTURE OF PLASMA-DERIVED FACTOR VIIA AND FACTOR X (MC710) IN HEMOPHILIA PATIENTS WITH INHIBITORS: HEMOSTATIC EFFICACY AND SAFETY

YUICHI SHINKODA
Thread initiator
Subspeciality
Reg: 4/17/2014 9:16:00 AM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 4/17/2014 9:16:00 AM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 2526
Title: A WEB SITE TO IMPROVE MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCY DEPARTMENT: RESULTS AT 2 YEARS
Authors: Annarita Tagliaferri ,
Centre: Centro di Riferimento Regionale per la cura dellEmofilia

Poster most viewed in this topic
Poster: 63
Visits: 314
Title: A Phase III clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in hemophilia patients with inhibitors: hemostatic efficacy and safety
Authors: YUICHI SHINKODA ,
Centre: Kagoshima City Hospital


 








PosterSessionOnline
Logo Draft
 
Logo Cert